An article of Asper Biotech’s participation of a cancer research project CTCtrap (circulating tumour cells) was just realised in the biggest Estonian newspaper. The CTCtrap method investigates the possibility of “catching” free circulating cancer cells from the bloodstream. In case of a success, this method could possibly lead to a solution where cancer, once beaten, would never return.
Anu Aaspõllu a senior scientist in Asper Biotech told that CTCtrap method would help to improve the cancer diagnostics and treatment significantly and is another step towards the personal medicine. The whole international study of eleven partners from seven countries is led by Leon Terstappen a professor of Medical Cell Biophysics of the University of Twente, The Netherlands. European Union is funding the research with 6 million Euros whilst the whole budget is much larger as all the partners must contribute from their side as well.
In case you are fluent in Estonian, you can read more from http://www.tartupostimees.ee/1145100/uus-meetod-ajab-vahirakud-loksu/.